C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 403/06 (2006.01) A61K 31/496 (2006.01) C07D 403/14 (2006.01) C07D 405/14 (2006.01)
Patent
CA 2649927
Certain novel substituted imidazole 4-carboxamides are ligands of the human cholecystokinin receptor and, in particular, are selective ligands of the human cholecystokinin-1 receptor (CCK-1R). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of CCK-1R, such as obesity, and diabetes.
L'invention concerne certains nouveaux imidazole 4-carboxamides substitués qui sont des ligands du récepteur de cholécystokinine humain et, en particulier, des ligands sélectifs du récepteur de cholécystokinine-1 (CCK-1R) humain. On les utilise donc pour traiter, combattre ou prévenir des maladies et des troubles qui réagissent à la modulation de CCK-1R, par exemple l'obésité et les différents types de diabète.
Berger Richard
Edmondson Scott
Hansen Alexa
Zhu Cheng
Merck & Co. Inc.
Merck Sharp & Dohme Corp.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Substituted imidazole 4-carboxamides as cholecystokinin-1... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted imidazole 4-carboxamides as cholecystokinin-1..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted imidazole 4-carboxamides as cholecystokinin-1... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1627495